Concurrent Technologies PLC
21 March 2006
21 March 2006
Concurrent Technologies plc
Director Shareholdings
Concurrent Technologies plc ('the Company') announces that it has been notified
today that the Trustees of the Self Invested Pension Plan of Michael Collins,
Non-Executive Chairman, sold 1,050,000 Ordinary Shares in the Company on 21
March 2006 at a price of 30 pence per share. Following the sale, his beneficial
holding is now 1,519,905 Ordinary Shares, representing 2.09% of the issued share
capital.
The Company was also notified today that on 20 March 2006, the Trustees of the
Self Invested Pension Plan of Peter Crowther, Non-Executive Director, also sold
500,000 Ordinary Shares in the Company at a price of 30 pence per share.
Following the sale, his beneficial holding is now 869,605 Ordinary Shares,
representing 1.2% of the issued share capital.
The purpose of these transactions was partly to meet institutional demand, to
enable the Directors concerned to achieve a better balance of investments in
their pension plans and to provide increased liquidity in the shares.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.